The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis - Wikidata - wikimedia - TriplyDB

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

http://www.wikidata.org/entity/Q34064171

about

Identification of Biomarkers for Breast Cancer Using Databases.miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.Ultrasensitive optical biosensor for detection of miRNA-155 using positively charged Au nanoparticles.

P2860

Q30239810-1F6185CF-B066-495F-8893-64F9A1109EC0 Q36544789-8845CE2F-C1B4-4619-A756-5675F2D81FBB Q50025836-314917ED-CD5A-47F6-8E93-BF41A1DC2ABE

P2860

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

http://www.wikidata.org/entity/Q34064171

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@ast

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@en

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@nl

type

label

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@ast

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@en

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@nl

prefLabel

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@ast

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@en

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@nl

P1433

Q34064171-BD360D62-C16A-42D7-B9FB-1E7348E71084

P1476

Q34064171-F86E8730-ECA3-4AEE-A08D-AF35E6C1172D

P2093

Q34064171-42F3E0E1-79B4-4A21-A35C-15694C9D4AE7

Q34064171-6543E316-3AC9-4AF9-B9E5-5C42C0F2A140

Q34064171-A5B9164A-0E1F-4AEC-8109-BEB9E580EB56

Q34064171-ACE0C991-F557-4BBA-BE8A-0284489B2935

Q34064171-B1C4C8E2-D430-449A-82C3-5BEC87AD2C38

P2860

Q34064171-1007A8D2-60C9-47B1-9967-589A7B2E6D3E

Q34064171-1CF35DB1-8896-41B5-A2CE-24FA5AF0AFB2

Q34064171-305A6FD3-15DF-4192-A25E-B0C4C56A19FF

Q34064171-3431839D-650F-48F2-A61B-9878D6E5B80A

Q34064171-45F15E48-D6BD-4D34-9591-43E43838CC61

Q34064171-468CAFC6-A9A5-492E-8FD8-616CEFD77062

Q34064171-601AE8BA-65F7-40BB-8CA8-E51F57E7AAE0

Q34064171-6802BD02-0BEF-49DB-B1D2-A7FC7D4244B7

Q34064171-781F8F54-2763-4159-B1B2-1BC1730FF89A

Q34064171-7D6C67FA-83D7-44B7-A443-EAB8B69D72C4

P304

Q34064171-FBDE7EB4-3EEA-40F7-8D3E-DF4FAEA2F6EA

P31

Q34064171-59CB94EB-DDAF-46BA-A362-333F99C76FB1

Q34064171-e266cf20-a0a4-4296-86e6-ea6726aff725

P356

Q34064171-F8356E1E-600A-4274-8E7A-7F8DDAAACFA8

P407

Q34064171-A1C56CD6-5CE7-4011-8EA6-03BC54CBFFC2

P478

Q34064171-60A9A99D-F4B2-48BF-AD78-419C12EF8A91

P577

Q34064171-CB7D8458-B9A2-455D-BC9B-435404BEAE85

P5875

Q34064171-050FA3BA-BE57-4748-ACBE-CC3407A5B7D4

P698

Q34064171-498FF720-0A87-4A60-A427-157EEA8FAD08

P921

Q34064171-494AC71E-ED96-4871-B8F3-9E3DA8B6D451

P932

Q34064171-9D6B4EE7-A1AB-4797-B590-013345BC25DA

P356

P1433

BioMed Research International

P1476

The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis

@en

P2093

Cheng Fang

http://www.w3.org/2001/XMLSchema#string

Hui Zeng

http://www.w3.org/2001/XMLSchema#string

Qing Cai

http://www.w3.org/2001/XMLSchema#string

Seungyoon Nam

http://www.w3.org/2001/XMLSchema#string

Xinghua Long

http://www.w3.org/2001/XMLSchema#string

P2860

Grading quality of evidence and strength of recommendations

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

MicroRNA gene expression deregulation in human breast cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

Mechanisms of gene silencing by double-stranded RNA

Ribo-gnome: the big world of small RNAs

miR-21-mediated tumor growth

MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.

P304

724209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/724209

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264973094

http://www.w3.org/2001/XMLSchema#string

P698

25157366

http://www.w3.org/2001/XMLSchema#string

P921

P932

4137503

http://www.w3.org/2001/XMLSchema#string